Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2004-02-17
2008-11-04
Schnizer, Richard (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S315000, C514S277000, C514S025000, C435S208000
Reexamination Certificate
active
07446098
ABSTRACT:
This application provides methods of improving gene therapy by combining gene therapy with active site-specific chaperones (ASSCs). The ASSC increases the stability and efficiency of the protein encoded by the recombinant gene that is administered.
REFERENCES:
patent: 6051598 (2000-04-01), Shayman et al.
patent: 6066626 (2000-05-01), Yew et al.
patent: 6200812 (2001-03-01), Pati et al.
patent: 6255113 (2001-07-01), Zarling et al.
patent: 6274597 (2001-08-01), Fan et al.
patent: 6589964 (2003-07-01), Fan et al.
patent: 6599919 (2003-07-01), Fan et al.
patent: 6774135 (2004-08-01), Fan et al.
patent: 2002/0035072 (2002-03-01), Fan et al.
patent: 2004/0204379 (2004-10-01), Cheng et al.
Verma et al (Nature 389:239-242, 1997) □□.
Anderson (Nature 392:25-30, 1998) □□.
Romano et al (Stem Cells 18: 19-39, 2000) □□.
Somia and Verma (Nature Reviews Genetics 1: 91-99, 2000).
Rosenfeld and Collins (Chest 109:241-252, 1996).
Rosenecker (Eur. J. Med. 23(3): 149-156, Mar. 1998).
Boucher (TIG 1.2(3): 81-84, 1996, p. 81, paragraph bridging columns 2 and 3).
Alton and Geddes (J. R. Soc. Med 90 Suppl 31: 43-46 1997).
Davies (Mol. Med Today 4(7): 292-299, Jul. 1998, pp. 294, col. 2, lines 20-28).
Boucher (J. Clin. Invest. 103(4): 441-445 Feb. 1999).
Wilson (J. Clin. Invest. 96: 2547-2554, 1995).
Ferrari et al (Adv. Drug Del. Rev 54:1373-1393, 2002).
Fan (Trends in Pharm. Sci. 24(7): 355-360, 2003).
Hendricks et al (Blood 96 (11 part 1): 845a, 2000).
Handa et al (Dermatology 200: 262-265, 2000).
Handa et al., 2000, “A case of symptomatic heterozygous female Fabry's disease without detectable mutation in the alpha-galactosidase gene,” Dermatology 200:262-265.
Baker & Botts LLP
Mount Sinai School of Medicine of New York University
Schnizer Richard
LandOfFree
Combination therapy for treating protein deficiencies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy for treating protein deficiencies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for treating protein deficiencies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4035740